Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-02-04Clinical Trial Update: Livial Intervention Following Breast Cancer; Efficacy, Recurrence and Tolerability Endpoints (LIBERATE)(COMPLETED)(P05885) [Phase 3]
Phase 3 trial update for LIBERATE evaluating livial intervention after breast cancer, reporting efficacy, recurrence, and tolerability endpo…
-
CLINICAL_TRIALS trial_result · 2022-02-04Clinical Trial Update: Estradiol Levels in Patients Treated With Estring [Phase 2]
Phase 2 trial results on estradiol levels in patients treated with Estring have been completed with results posted.
-
FDA approval · 2022-02-02FDA Approved: KADCYLA — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for KADCYLA (ado-trastuzumab emtansine) submitted by Genentech, Inc., signaling an updated/expanded …
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX) [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigating metronomic cyclophosphamide (CP) and JX-594 in patients with advanced breast cancer and advanced so…
-
CLINICAL_TRIALS trial_result · 2022-02-01Clinical Trial Update: STAR Cape+BKM120 MBC With Brain Met [Phase 2]
A Phase 2 clinical trial update for STAR Cape+BKM120 in metastatic breast cancer with brain metastases has completed enrollment with results…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-02-01Clinical Trial Update: Cardiotoxicity Prevention in Breast Cancer Patients Treated With Anthracyclines and/or Trastuzumab [Phase 3]
Phase 3 clinical trial update addressing cardiotoxicity prevention in breast cancer patients treated with anthracyclines and/or trastuzumab.
-
CLINICAL_TRIALS trial_result · 2022-02-01Clinical Trial Update: Neoadj ph 2 AI Plus Everolimus in Postmenopausal Women w/ ER Pos/HER2 Neg, Low Risk Score [Phase 2]
Phase 2 neoadjuvant trial evaluating AI plus everolimus in postmenopausal women with ER+/HER2-, low risk breast cancer; study terminated wit…
-
CLINICAL_TRIALS trial_result · 2022-02-01Clinical Trial Update: Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer After Anthracycline Failure (CAT) [Phase 2]
Phase 2 trial evaluating chloroquine in combination with taxane chemotherapy for advanced or metastatic breast cancer after prior anthracycl…
-
CLINICAL_TRIALS trial_result · 2022-01-28Clinical Trial Update: Ultrasound-assisted CNSs Mapping Versus Dual-tracer-guided Sentinel Lymph Node Biopsy [Phase 3]
Phase 3 trial comparing ultrasound-assisted CNS mapping to dual-tracer-guided sentinel lymph node biopsy in breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-01-27Clinical Trial Update: Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer [Phase 1]
This document describes a Phase 1 dose-escalation and expansion study of GSK525762 in combination with fulvestrant for hormone receptor-posi…
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: Surgical Site Infection With 0.05% Chlorhexidine (CHG) Compared to Triple Antibiotic Irrigation [NA]
Clinical trial comparing surgical site infection rates using 0.05% chlorhexidine versus triple antibiotic irrigation in breast cancer surger…
-
FDA approval · 2022-01-21FDA Approved: IXEMPRA — Supplemental Application (R-Pharm US Operating, LLC)
The FDA approved a supplemental application for IXEMPRA (ixabepilone) submitted by R-Pharm US Operating, LLC. The action updates the product…
-
CLINICAL_TRIALS trial_result · 2022-01-21Clinical Trial Update: Radiation Dose Intensity Study in Breast Cancer in Young Women [Phase 3]
Phase 3 clinical trial update on radiation dose intensity in breast cancer for young women.
-
CLINICAL_TRIALS trial_result · 2022-01-20Clinical Trial Update: Poziotinib in Patients With HER2+ Recurrent Stage IV BC Who Have Received at Least 2 Prior HER2-directed Regimens [Phase 2]
Phase 2 clinical trial update for poziotinib in HER2+ metastatic breast cancer patients after at least two prior HER2-directed regimens.
-
CLINICAL_TRIALS trial_result · 2022-01-19Clinical Trial Update: T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial) [Phase 2]
The Phase 2 ATEMPT trial comparing trastuzumab emtansine (T-DM1) to paclitaxel plus trastuzumab in breast cancer has completed and results w…
-
CLINICAL_TRIALS trial_result · 2022-01-19Clinical Trial Update: BRCA1/2 and Effect of Mifepristone on the Breast [Phase 2]
Phase 2 trial investigating mifepristone in women with BRCA1/2 mutations (breast cancer susceptibility).
-
CLINICAL_TRIALS trial_result · 2022-01-19Clinical Trial Update: Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab with metronomic chemotherapy, diet, and exercise after preoperative chemotherapy for breast cancer; stu…
-
CLINICAL_TRIALS trial_result · 2022-01-19Clinical Trial Update: Phase I Study of MLN0128 and MLN8237 in Patients With Advanced Solid Tumors and Metastatic Triple-negative Breast Cancer [Phase 1]
Phase I study of MLN0128 and MLN8237 in patients with advanced solid tumors and metastatic triple-negative breast cancer completed; results …
-
CLINICAL_TRIALS trial_result · 2022-01-18Clinical Trial Update: Nipple-Areola Complex (NAC) Irradiation After Nipple-Sparing Mastectomy and Reconstruction [NA]
Clinical trial update regarding nipple-areola complex irradiation after nipple-sparing mastectomy with reconstruction; the study is active b…
-
CLINICAL_TRIALS trial_result · 2022-01-18Clinical Trial Update: T-DM1 and Non-pegylated Liposomal Doxorubicin in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer [Phase 1]
Phase 1 trial evaluating T-DM1 with non-pegylated liposomal doxorubicin in HER2-positive metastatic breast cancer has completed with results…
-
FDA approval · 2022-01-14FDA Approved: CAPECITABINE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for Capecitabine from Dr. Reddy's Laboratories Limited.
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer [Phase 3]
Phase 3 trial comparing TX05 with Herceptin in HER2-positive early breast cancer has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: The Gamma Pod: A Clinical Feasibility Study Device GCC 1202: The Gamma Pod: A Clinical Feasibility Study [NA]
Clinical feasibility study of The Gamma Pod device for breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: Clinical Study of Fulvestrant Combined With Chidamide in the Treatment of Hormone Receptor-positive Advanced Breast Cancer Resistant to CDK4/6 Inhibitors [Phase 4]
A Phase 4 clinical trial evaluating fulvestrant in combination with chidamide for hormone receptor-positive advanced breast cancer resistant…
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: Comparison of Different Volumes Spread of Erector Spinae Block in Post Mastectomy Pain Syndrome Management [Phase 2]
Phase 2 clinical trial evaluating varying volumes of erector spinae block for post-mastectomy pain syndrome in breast cancer patients.